This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (175)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Elana J. Bloom, MD; Donald I. Abrams, MD; George Rodgers, MD, PhD

JAMA. 1986;256(4):491-493.

Abstract
Prolongation of partial thromboplastin time was noted in patients with acquired immunodeficiency syndrome (AIDS) who were admitted to the hospital for diagnosis of opportunistic infection. As biopsy procedures were often indicated, detailed investigation of the abnormal coagulation study was performed in four patients. Results confirmed the presence of a lupus anticoagulant. Partial thromboplastin times of 34 consecutive subsequent patients hospitalized with the diagnosis of AIDS-associated opportunistic infection were recorded; prolongation was noted in 24 of these. None of these 38 patients exhibited clinical evidence of bleeding. One patient had a confirmed thrombotic episode. Prolonged partial thromboplastin time is a common finding in hospitalized patients with AIDS and opportunistic infection. If no clinical history of unusual bleeding is noted, the lupus anticoagulant should be suspected. Many patients with AIDS require invasive procedures for disease management; the lupus anticoagulant, an in vitro phenomenon, should not prevent these studies.

(JAMA 1986;256:491-493)

Author Affiliations
From the Department of Medicine, San Francisco General Hospital (Drs Abrams and Rodgers), and the Cancer Research Institute, University of California, San Francisco (Drs Bloom, Abrams, and Rodgers).

Footnotes
Reprint requests to San Francisco General Hospital, AIDS Clinic, Bldg 80, Ward 84, 995 Potrero Ave, San Francisco, CA 94110 (Dr Abrams).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relationship between Progression to AIDS and Thrombophilic Abnormalities in HIV Infection
Lijfering et al.
Clin. Chem. 2008;54:1226-1233.
ABSTRACT | FULL TEXT  

Venous Thrombosis Among Patients with AIDS
Majluf-Cruz et al.
CLIN APPL THROMB HEMOST 2004;10:19-25.
ABSTRACT  

Cutaneous Histopathologic Findings in `Antiphospholipid Syndrome' Correlation With Disease, Including Human Immunodeficiency Virus Disease
Smith et al.
Arch Dermatol 1990;126:1176-1183.
ABSTRACT  

Dextran Sulfate Is Poorly Absorbed after Oral Administration
Lorentsen et al.
ANN INTERN MED 1989;111:561-566.
ABSTRACT  

Anticardiolipin Antibodies in Acquired Immunodeficiency Syndrome
Stimmler et al.
Arch Intern Med 1989;149:1833-1835.
ABSTRACT  

Rheumatologic Manifestations of Infection with Human Immunodeficiency Virus (HIV)
Kaye
ANN INTERN MED 1989;111:158-167.
ABSTRACT  

Peripheral Neuropathy Associated With Acquired Immunodeficiency Syndrome: Prevalence and Clinical Features From a Population-Based Survey
So et al.
Arch Neurol 1988;45:945-948.
ABSTRACT  

The Relationship Between Lupus Anticoagulants and Antibodies to Phospholipid
Triplett et al.
JAMA 1988;259:550-554.
ABSTRACT  

Circulating Anticoagulant in the Acquired Immunodeficiency Syndrome
LEFRERE et al.
ANN INTERN MED 1987;107:429-430.
ABSTRACT  

The Spectrum of Neurologic Disease Associated With Antiphospholipid Antibodies: Lupus Anticoagulants and Anticardiolipin Antibodies
Levine and Welch
Arch Neurol 1987;44:876-883.
ABSTRACT  

Disseminated Sporotrichosis in a Patient With HIV Infection After Treatment for Acquired Factor VIII Inhibitor
Bibler et al.
JAMA 1986;256:3125-3126.
ABSTRACT